title: Release of active tissue factor by human arterial smooth muscle cells.
abstract: Tissue factor (TF), the initiator of coagulation, is thought to function predominantly at the cell surface. Recent data have suggested that active TF is present extracellularly in atherosclerotic plaques, the arterial wall, and the blood. This study was conducted to determine whether smooth muscle cells (SMCs), a major source of arterial TF, could generate extracellular TF. Active TF accumulated in the medium of cultured human SMCs, representing approximately 10% of that measured in the underlying cells at 24 hours. Platelet-derived growth factor, phorbol ester, and tumor necrosis factor-alpha caused approximately 3-fold increases in TF activity in the medium. Release of TF into the medium was dependent on the presence of the TF transmembrane domain but not the cytoplasmic domain. Antibodies to TF precipitated most of the activity from the culture medium, whereas antibodies to the beta(1)-integrin subunit precipitated approximately 33% of the activity. Treatment with detergent or phosphatidylserine:phosphatidylcholine did not increase activity, suggesting that all TF released by SMCs was in the appropriate lipid milieu and not encrypted. Western blotting showed that the medium contained full-length TF protein. Fluorescent cytometry showed that extracellular TF was present largely in particles < or =200 nm, which had a density of 1.10 g/mL. We hypothesize that active extracellular TF found in the injured arterial wall and atherosclerotic plaques derives, in part, from SMC microparticles.
authors.affiliation: Cardiovascular Institute, Department of Medicine, Mount Sinai School of Medicine, New York, NY 10029, USA.
authors.forename: A D
authors.initials: AD
authors.lastname: Schecter
authors.forename: B
authors.initials: B
authors.lastname: Spirn
authors.forename: M
authors.initials: M
authors.lastname: Rossikhina
authors.forename: P L
authors.initials: PL
authors.lastname: Giesen
authors.forename: V
authors.initials: V
authors.lastname: Bogdanov
authors.forename: J T
authors.initials: JT
authors.lastname: Fallon
authors.forename: E A
authors.initials: EA
authors.lastname: Fisher
authors.forename: L M
authors.initials: LM
authors.lastname: Schnapp
authors.forename: Y
authors.initials: Y
authors.lastname: Nemerson
authors.forename: M B
authors.initials: MB
authors.lastname: Taubman
mesh_terms: D001011:Aorta; D002478:Cells, Cultured; D003331:Coronary Vessels; D006801:Humans; D007213:Indomethacin / Q000494:pharmacology; D007375:Interleukin-1 / Q000494:pharmacology; D007700:Kinetics; D008545:Melanoma; D009131:Muscle, Smooth, Vascular / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D010982:Platelet-Derived Growth Factor / Q000494:pharmacology; D011994:Recombinant Proteins / Q000378:metabolism; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology; D013925:Thromboplastin / Q000235:genetics / Q000378:metabolism*; D014162:Transfection; D014407:Tumor Cells, Cultured; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology
chemical_list: D007375:Interleukin-1; D010982:Platelet-Derived Growth Factor; D011994:Recombinant Proteins; D014409:Tumor Necrosis Factor-alpha; D013925:Thromboplastin; D013755:Tetradecanoylphorbol Acetate; D007213:Indomethacin